Improving the Quality of Life of Latin American Patients
M8 provides healthcare professionals and patients with access to proven treatments they need to thrive. We serve as a comprehensive source of expertise in each of the following therapeutic areas.
Central Nervous System
- Atarax®(Hydroxyzine)
- Concerta®(Methylphenidate)
- Mokbio®(Lactobacillus plantarum 128)
- Haldol®(Haloperidol )
- Lexotan®(Bromazepam)
- Nabota®(Botulinum Toxin type A)
- Razapina®(Mirtazapina)
- Reminyl®(Galantamine Bromhide)
- Risperdal®(Risperidone)
- Seroquel®(Quetiapine)
- Sibelium®(Flunarizine)
- Topamax®(Topiramate)
- Nootropil®(Piracetam)
- Valium®(Diazepam)
- Diacomit®(Stiripentol)
Cardiometabolism
Oncology & Hematology
Reliable, Convenient Service and Support for Professionals and Patients
Partner with Us
From go-to-market strategy and registration to access and long-term market presence, M8 is a purpose-built biopharmaceutical platform that supports the entire development-commercialization continuum.
Our Commitment to Latin America
Six core values guide us on our mission to provide support to the patients and healthcare professionals of Latin America.
Inderalici®
Generic: Propranolol
Description
• Control of hypertension. • Management of angina pectoris. • Long-term prophylaxis after recovery from acute myocardial infarction. • Control of cardiac arrhythmias. • Migraine prophylaxis. • Management of essential tremor. • Control of anxiety and anxiety tachycardia. • Prophylaxis of upper gastrointestinal bleeding in patients with portal hypertension and esophageal varices. • Auxiliary management of thyrotoxicosis and thyrotoxic crisis. • Management of obstructive hypertrophic cardiomyopathy and tetralogy of Fallot. • Pheochromocytoma management (INDERALICI® should be initiated only in the presence of an effective alpha-blocker). • Glaucoma management.